title: An overview of the highly pathogenic H5N1 influenza virus.
abstract: Since the first human case of H5N1 avian influenza virus infection was reported in 1997, this highly pathogenic virus has infected hundreds of people around the world and resulted in many deaths. The ability of H5N1 to cross species boundaries, and the presence of polymorphisms that enhance virulence, present challenges to developing clear strategies to prevent the pandemic spread of this highly pathogenic avian influenza (HPAI) virus. This review summarizes the current understanding of, and recent research on, the avian influenza H5N1 virus, including transmission, virulence, pathogenesis, clinical characteristics, treatment and prevention.
authors: The State Key laboratory of Virology and College of Life Sciences, Wuhan University, Wuhan 430072, China.
authors: Jingchuan
authors: J
authors: Yin
authors: Shi
authors: S
authors: Liu
authors: Ying
authors: Y
authors: Zhu
mesh_terms: D000818:Animals; D000998:Antiviral Agents / Q000627:therapeutic use; D006801:Humans; D053124:Influenza A Virus, H5N1 Subtype / Q000187:drug effects / Q000235:genetics / Q000472:pathogenicity* / Q000502:physiology; D007251:Influenza, Human / Q000188:drug therapy / Q000276:immunology / Q000635:transmission / Q000821:virology*; D014764:Viral Proteins / Q000235:genetics / Q000378:metabolism; D014774:Virulence
chemical_list: D000998:Antiviral Agents; D014764:Viral Proteins